{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
Combining clinical safety* and ease-of-use, the Cordis EXOSEAL Vascular Closure Device (VCD) means a more confident close and improved patient outcomes.** Product Description Combining clinical safety* ...
Cordis
... and predictable deployment of MYNX CONTROL™ Vascular Closure Device delivers outstanding performance and control, for reliable secure arterial closures.* Product Description MYNX ...
Cordis
The MYNXGRIP™ Vascular Closure Device (VCD) achieves secure extravascular closure by utilizing the GRIP™ sealant, which actively adheres to the artery or vein. The MYNXGRIP™ ...
Cordis
... commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial access site closure.1 Available in 14 Fr. and 18 Fr., ...
ARTERIAL CLOSURE DEVICE A faster, easier and more effective solution for your closure needs. In 3 simple steps the CELT ACD offers rapid haemostasis and immediate patient ambulation ...
VenaBLOCK Varicose Vein Closure System VenaBLOCKⓇ offers a unique treatment for venous insufficiency. Treatment is simply delivering cyanoacrylate inside of the dysfunctioning vein segment. (VSM, VSP, ...
... developed and received PMA approval and CE Mark for Celt ACD®, an arterial puncture closure device which affects the closure of a puncture site after percutaneous catheter-based vascular ...
Please specify:
Help us improve:
remaining